Physician profile
Ashley Clark
NPI 1588207807
$2,052.41
in general payments reported to CMS, 2019-2025
17 companies · $1,530 in 2025
The $1,530 reported for 2025 was more than what 88% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2024: $397 · 2025: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $553.84 | 2025 | Fanapt, Hetlioz |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $237.27 | 2025 | Caplyta |
| Inari Medical, INC. | $198.40 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbvie INC. | $193.16 | 2024-2025 | |
| Axsome Therapeutics, INC. | $182.14 | 2025 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $98.24 | 2024-2025 | Trintellix, Fruzaqla |
| Almatica Pharma LLC | $95.03 | 2025 | Loreev Xr |
| Alkermes, INC. | $71.10 | 2025 | Lybalvi, Aristada |
| Otsuka America Pharmaceutical, INC. | $62.20 | 2025 | Rexulti |
| Collegium Pharmaceutical, INC. | $54.98 | 2025 | Jornay Pm |
| Tris Pharma INC | $49.29 | 2024-2025 | Dyanavel Xr |
| Idorsia Pharmaceuticals US INC | $40.03 | 2025 | Quviviq |
| Corium, LLC | $30.86 | 2025 | Azstarys |
| E.R. Squibb & Sons, L.L.C. | $25.19 | 2025 | Cobenfy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $21.25 | 2025 | Spravato |
| Supernus Pharmaceuticals, INC. | $14.43 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.